Gw&K Investment Management, LLC Oyster Point Pharma, Inc. Transaction History

Gw&K Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$7.95 - $11.68 $84,015 - $123,434	-10,568 Reduced 1.87%	554,288 $6.19 Million
Q3 2022 Nov 09, 2022	BUY	$4.41 - $8.38 $443,085 - $841,963	100,473 Added 21.64%	564,856 $3.17 Million
Q2 2022 Aug 09, 2022	BUY	$3.6 - $11.2 $36,777 - $114,419	10,216 Added 2.25%	464,383 $2.01 Million
Q1 2022 May 09, 2022	BUY	$8.58 - $17.65 $715,426 - $1.47 Million	83,383 Added 22.49%	454,167 $5.29 Million
Q4 2021 Feb 11, 2022	SELL	$10.17 - $18.96 $182,510 - $340,256	-17,946 Reduced 4.62%	370,784 $6.77 Million
Q3 2021 Nov 10, 2021	SELL	$11.67 - $18.07 $63,986 - $99,077	-5,483 Reduced 1.39%	388,730 $4.61 Million
Q2 2021 Aug 10, 2021	SELL	$16.25 - $21.51 $131,137 - $173,585	-8,070 Reduced 2.01%	394,213 $6.78 Million
Q1 2021 May 11, 2021	BUY	$17.92 - $25.86 $920,317 - $1.33 Million	51,357 Added 14.63%	402,283 $7.35 Million
Q4 2020 Feb 05, 2021	BUY	$18.13 - $25.18 $1.24 Million - $1.72 Million	68,219 Added 24.13%	350,926 $6.6 Million
Q3 2020 Nov 10, 2020	BUY	$17.83 - $29.12 $2.27 Million - $3.71 Million	127,274 Added 81.88%	282,707 $5.97 Million
Q2 2020 Aug 06, 2020	BUY	$27.86 - $35.93 $4.33 Million - $5.58 Million	155,433 New	155,433 $4.49 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.